Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation

NCT00128739 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Graft Vs Host Disease

Interventions

DRUG: Budesonide

Sponsor

Rafa Laboratories

Collaborators

[object Object]